SOURCE: NVISION Eye Centers

NVISION Eye Centers

June 01, 2015 13:31 ET

NVISION Eye Centers Performs First KAMRA™ Inlay in California

Innovative Leader in Ophthalmology Is the First in the State to Perform This Revolutionary Procedure to Correct Near Vision Loss Associated With Aging

ALISO VIEJO, CA--(Marketwired - Jun 1, 2015) -  NVISION Eye Centers, one of the largest providers of LASIK and cataract surgery in the U.S., has successfully performed the first in California KAMRA™ inlay procedure designed to treat presbyopia, a condition causing the loss of near vision that affects nearly everyone over the age of 40. NVISION performed California's first KAMRA inlay procedure, Thursday, May 21, at its Newport Beach, Calif. location. Dr. Tom Tooma, NVISION founder and LASIK pioneer, performed the groundbreaking procedure and is pleased with how smoothly it went; and, the patient is recovering well.

"I could not be more pleased with the execution of this new procedure," said Dr. Tooma. "And, I look forward to watching our patient's daily life improve -- without the need for additional corrective eyewear."

According to the American Academy of Ophthalmology, more than 1 billion people worldwide suffer from presbyopia, a decrease in near vision due to the natural aging of the internal lens of the eye.

Developed by AcuFocus, Inc., the Irvine, Calif.-based global leader in corneal inlay technology, the KAMRA inlay is a first-of-its-kind outpatient procedure performed in approximately 15 minutes. Implanted in a pocket within the cornea, the KAMRA inlay relies on small aperture optics designed to increase depth-of-focus. Smaller and thinner than a contact lens, the KAMRA inlay is the first U.S. FDA-approved procedure that can restore near vision without compromising distance vision. NVISION has been heavily involved in the research and development of the KAMRA inlay procedure, directly participating in the decade of numerous clinical trials that resulted in the U.S. FDA approval of this long-awaited treatment.

"It was an honor to be a part of the first KAMRA inlay performed in California," says Dr. Tom Tooma, who was a principle investigator in the clinical trials for the KAMRA inlay. "We spent years working to bring this groundbreaking technology to American ophthalmology and I am proud to see it now helping our patients restore sight."

NVISION doctors are among the most distinguished, experienced and educated surgeons having trained more than 1,900 eye doctors throughout California, Nevada and Oregon in laser vision correction. In fact, five of NVISION's centers have been selected as "Centers of Excellence" by AcuFocus for the launch of the KAMRA inlay. NVISION doctors provide the latest cutting-edge technologies to assist them in recognizing those patients who could benefit from LASIK, cataract and now KAMRA inlay procedures.

"The procedure went as expected and I'm encouraged by the progress so far," says Fernie Molina, who agreed to be NVISION's first patient to undergo the procedure. "I'm excited to just pick up a menu or a magazine like I used to -- without having to reach for my glasses."

For more information, call 888-636-0203 or visit: www.nvisioncenters.com.

ABOUT NVISION EYE CENTERS: NVISION Eye Centers is one of the largest providers of LASIK and cataract surgery in the U.S., with 18 centers in California, Nevada and Oregon. An innovative leader in ophthalmology, NVISION is dedicated to providing the best patient experience through the use of the latest technology and treatment by the most talented and experienced surgeons in the industry. NVISION was founded in 2010 by Tom Tooma, M.D., one of the earliest pioneers of LASIK who has performed more than 100,000 procedures throughout his esteemed career. With more than 1,900 eye doctors referring their patients and trusting their own eyes to NVISION surgeons, NVISION Eye Centers is the Eye Doctors' #1 Choice®. For more information, visit www.NVISIONCenters.com or call 877-91NVISION (877-916-8474).

Editor's Note: A b-roll package is available to interested members of the press and NVISION doctors are readily available for comment.

Contact Information